City
Epaper

S. Korea to ban remote prescription of weight loss medication

By IANS | Updated: November 29, 2024 16:50 IST

Seoul, Nov 29 South Korea's health ministry on Friday said it will ban remote prescribing of weight loss ...

Open in App

Seoul, Nov 29 South Korea's health ministry on Friday said it will ban remote prescribing of weight loss medications, including Wegovy, released in the country in October, to prevent potential abuse.

According to the Ministry of Health and Welfare, the decision to ban remote prescribing of weight loss medications will take effect Monday, with a two-week grace period, Yonhap news agency reported.

The move comes amid growing concerns over the abuse and illegal sales of such medications, particularly due to the growing popularity of Wegovy, which was developed by Denmark-based Novo Nordisk.

The government also plans to establish guidelines for telemedicine consultations regarding such medications within the first half of 2025, the health ministry added.

South Korea has been temporarily allowing telemedicine consultations amid the ongoing walkout by trainee doctors at general hospitals, which began in February.

Wegovy was launched in South Korea on November 15. It is a weight management medication that can treat obesity and has gained international attention as a “miracle weight loss drug”.

The Health Ministry stressed that medical institutions should “avoid promoting the drug in ways that might lead patients to believe it can be easily prescribed for general weight loss purposes” and “take special precautions to prevent misuse when prescribing through telemedicine.”

As per the current regulations, Wegovy must only be prescribed to patients with a body mass index (BMI) of 30 or higher. Adults with a BMI between 27 and 30 who have conditions such as hypertension or dyslipidemia can also be prescribed the drug.

The Health Ministry has also requested medical institutions to comply with the Food and Drug Safety Administration’s approval conditions. Before prescribing the medication, patients must be informed about potential side effects, which include gallbladder disease and pancreatitis, it said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentSomy Ali recalls how Sanjay Dutt made her feel comfortable while shooting for 'Andolan'

BusinessIndia would be $25 trillion powerhouse by 2050: Gautam Adani

EntertainmentDil Dhadakne Do to Raksha Bandhan: Rakhi Special Must-Watch Movies That Celebrates Brother Sister Bond

AurangabadThree young dancers to make Bharatanatyam debut on Sunday

Other SportsPakistan captain Fatima Sana reprimanded for dissent in first T20I against Ireland

Technology Realted Stories

TechnologyMyntra sees 20 pc growth in handloom demand, boosts role as platform for India’s artisan, textile heritage

TechnologyMapMyIndia’s Q1 profit falls 6.5 pc sequentially, revenue slips

Technology81 pc Indians use Facebook, Instagram and WhatsApp to discover financial products: Report

TechnologyHealthy habits can slash future risks to heart in women with gestational diabetes

TechnologyStudy shows AI chatbots can blindly repeat incorrect medical details